Concourse Financial Group Securities, Inc. Cidara Therapeutics, Inc. Transaction History

Concourse Financial Group Securities, Inc.

$1.52 Billion
Q1 2024

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 30, 2024	BUY	$0.64 - $0.92 $0 - $0	0 New	0 $0
Q4 2023 Feb 07, 2024	BUY	$0.68 - $0.97 $0 - $0	0 New	0 $0
Q3 2023 Oct 30, 2023	BUY	$0.77 - $1.16 $0 - $0	0 New	0 $0
Q3 2023 Oct 25, 2023	BUY	$0.77 - $1.16 $0 - $0	0 New	0 $0
Q2 2023 Aug 10, 2023	BUY	$1.01 - $1.42 $0 - $0	0 New	0 $0

Q1 2023 May 15, 2023	BUY	$0.75 - $1.98 $0 - $0	0 New	0 $0
Q4 2022 Jan 30, 2023	BUY	$0.48 - $0.76 $0 - $0	0 New	0 $0
Q3 2022 Nov 15, 2022	BUY	$0.45 - $0.81 $0 - $0	0 New	0 $0
Q2 2022 Aug 09, 2022	BUY	$0.43 - $0.91 $0 - $0	0 New	0 $0
Q1 2022 May 09, 2022	BUY	$0.67 - $1.39 $0 - $0	0 New	0 $0
Q4 2021 Feb 07, 2022	BUY	$1.18 - $2.18 $0 - $0	0 New	0 $0
Q3 2021 Nov 09, 2021	BUY	$1.48 - $2.35 $0 - $0	0 New	0 $0
Q2 2021 Aug 13, 2021	BUY	$1.87 - $2.7 $0 - $0	0 New	0 $0
Q1 2021 May 13, 2021	BUY	$2.06 - $3.01 $0 - $0	0 New	0 $0
Q4 2020 Feb 02, 2021	BUY	$1.99 - $3.25 $0 - $0	0 New	0 $0
Q3 2020 Nov 13, 2020	BUY	$2.85 - $4.1 $0 - $0	0 New	0 $0
Q2 2020 Aug 13, 2020	BUY	$2.39 - $4.0 $0 - $0	0 New	0 $0
Q1 2020 May 13, 2020	BUY	$1.74 - $4.26 $0 - $0	0 New	0 $0
Q4 2019 Feb 14, 2020	BUY	$1.77 - $3.84 $0 - $0	0 New	0 $0
Q3 2019 Nov 13, 2019	BUY	$1.25 - $2.35 $0 - $0	0 New	0 $0
Q2 2019 Aug 13, 2019	BUY	$1.49 - $2.94 $0 - $0	0 New	0 $0
Q1 2019 May 15, 2019	BUY	$2.35 - $3.27 $0 - $0	0 New	0 $0
Q4 2018 Feb 14, 2019	BUY	$2.1 - $4.5 $0 - $0	0 New	0 $0
Q3 2018 Nov 13, 2018	BUY	$3.7 - $5.25 $0 - $0	0 New	0 $0

Others Institutions Holding CDTX

# of Institutions

Shares Held

22.2M

Call Options Held

2.7K

Put Options Held

100

Bvf Inc San Francisco, CA

6.86M
Shares

$76.9 Million
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

3.35M
Shares

$37.5 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

2.55M
Shares

$28.6 Million
0.0% of portfolio
Alethea Capital Management, LLC San Diego, CA

1.6M
Shares

$17.9 Million
1.21% of portfolio
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct

1.25M
Shares

$14 Million
0.0% of portfolio

View Full List

About Cidara Therapeutics, Inc.

Ticker CDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,075,696
Market Cap $786M
Description
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...

More about CDTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account